Sponsor
Wockhardt
Clinical research sponsor
Clinical trials
9 shownImmunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsNCT01398670 · lead sponsor · 2012-02-01
WITHDRAWNComparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DMNCT01357603 · lead sponsor · 2011-06-01
COMPLETEDImmunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsNCT01308437 · lead sponsor · 2011-03-01
TERMINATEDComparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy SubjectsNCT01358435 · lead sponsor · 2011-01-01
COMPLETEDComparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy SubjectsNCT00772265 · lead sponsor · 2010-09-01
COMPLETEDComparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 DiabeticsNCT00752180 · lead sponsor · 2008-08-01
COMPLETEDComparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.NCT00719108 · lead sponsor · 2008-07-01
COMPLETEDComparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.NCT00596063 · lead sponsor · 2008-01-01
COMPLETEDImmunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic PatientsNCT01352663 · lead sponsor
WITHDRAWNSponsor roles
lead sponsor9
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.